Jefferies 2014 Global Healthcare Conference in London

You are invited to attend the Jefferies Global Healthcare Conference on 19-20 November, 2014, at the Waldorf Hilton in London.

Now in its fifth year, ours is the largest healthcare-dedicated conference in Europe. Last year, we had 230 participating healthcare companies with a combined market capitalisation of over INVITATION $1 trillion and close to 2,250 1x1/small-group meetings. The 2014 conference is set to follow 19-20 NOVEMBER 2014 in the same footsteps, featuring leading public and private companies from areas of

The Waldorf Hilton pharmaceuticals, biotechnology, generics, consumer health, animal health, medical London, UK technology and healthcare services from the United States, Western and Emerging Europe, Middle East & Africa, Latin America, Russia, India, Israel, China, and Japan.

This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near and long-term investment opportunities and discuss the mechanisms driving global healthcare.

We hope you can join us for what promises to be a unique and comprehensive view of the industry.

Registration is now open. Please email your Jefferies representative if you are interested in attending.

For general questions, please email [email protected] or contact your Jefferies representative

© 2014 Jefferies LLC. Member SIPC.

AGENDA WEDNESDAY, NOVEMBER 19, 2014 Jefferies 2014 Global Healthcare Conference in London

TRACK 1 TRACK 2 TRACK 3 TRACK 4 TRACK 5 ADELPHI 1 ADELPHI 2 ADELPHI 3 EXECUTIVE BOARDROOM ALDWYCH 7:30 AM Breakfast and Registration

8:00 AM EMIS Group PLC( AIM:EMIS) Auris Medical Holding AG Sartorius AG (DB:SRT) Medivation, Inc.(NasdaqGS:MDVN) Ethypharm SA (Private) Healthcare Technology (NasdaqGM:EARS) Medical Products & Devices Biotechnology Pharmaceuticals Chris Spencer, CEO Pharmaceuticals Joerg Pfirrmann, CFO David Hung, M.D., President and CEO Hugues Lecat, CEO and Chairman of the Dr. Thomas Meyer, CEO Management Board

8:40 AM Circassia Limited (LSE:CIR) Amgen Inc. (NasdaqGS:AMGN) Spectrum Pharmaceuticals, Inc. PDL BioPharma, Inc. (NasdaqGS:PDLI) Ablynx NV (ENXTBR:ABLX) Biotechnology Biotechnology (NasdaqGS:SPPI) Life Sciences Biotechnology Steven Harris, CEO Arvind Sood, Vice President of IR Biotechnology John McLaughlin, President & CEO Edwin Moses, CEO Rajesh Shrotriya, Chairman & Chief Executive Officer

9:20 AM BTG Plc (LSE:BTG) Acorda Therapeutics, Inc. Gerresheimer AG (DB:GXI) CTI BioPharma Corp. (NasdaqCM:CTIC) ReWalk Robotics Ltd. (NasdaqGM:RWLK) Biotechnology (NasdaqGS:ACOR) Medical Products & Devices Biotechnology Medical Products & Devices Louise Makin, CEO Biotechnology Mrs. Anke Linnartz, Director Corporate Jim Bianco, President and CEO Larry Jasinski, CEO Andrew Blight, Chief Scientific Officer Investor Relations & Creditor Relations

10:00 AM Hikma Pharmaceuticals plc (LSE:HIK) Swedish Orphan Biovitrum AB Henry Schein, Inc. (NasdaqGS:HSIC) Actelion Ltd. (SWX:ATLN) Flamel Technologies SA Pharmaceuticals (OM:SOBI) Healthcare Services Biotechnology (NasdaqGM:FLML) Khalid Nabilsi, CFO Pharmaceuticals Ferdinand Jahnel, VP & Treasurer Andrew Weiss, Head Investor Relations & Pharmaceuticals Corporate Communications Michael Anderson, CEO Geoff McDonough, CEO

10:40 AM Pacira Pharmaceuticals Inc. Reckitt Benckiser Pharmaceuticals GN Store Nord A/S (CPSE:GN) Cosmo Pharmaceuticals SpA uniQure N.V. (NasdaqGS:QURE) (NasdaqGS:PCRX) (Indivior)(LSE:RB.) Medical Products & Devices (SWX:COPN) Biotechnology Pharmaceuticals Michael Bjergby, Vice President - Biotechnology Jörn Aldag, CEO Pharmaceuticals Shaun Thaxter, CEO Alessandro Della Cha, CEO Jim Scibetta, Senior Vice President & CFO IR & Treasury

11:20 AM Spire Healthcare Group Plc (LSE:SPI) Novartis AG (SWX:NOVN) PerkinElmer, Inc. (NYSE:PKI) Tesaro, Inc (NasdaqGS:TSRO) Immune Design Corp. (NasdaqGM:IMDZ) Healthcare Services Pharmaceuticals Life Sciences Tools and Services Biotechnology Biotechnology Antony Mannion, Investor Relations Rainer Boehm, Chief Commercial Officer Robert Friel, Chairman and CEO Lonnie Moulder, CEO Carlos Paya, CEO Director

12:00 PM Break – Working Lunch

Presenting companies and speakers are subject to change. AGENDA WEDNESDAY, NOVEMBER 19, 2014 Jefferies 2014 Global Healthcare Conference in London

TRACK 1 TRACK 2 TRACK 3 TRACK 4 TRACK 5 ADELPHI 1 ADELPHI 2 ADELPHI 3 EXECUTIVE BOARDROOM ALDWYCH

12:20 PM Clinigen Group Plc (AIM:CLIN) Laboratorios Farmaceuticos ROVI, S.A. Panel - Trials and tribulations of emerging Pixium Vision (PIX FP) Cempra, Inc. (NasdaqGM:CEMP) Healthcare Services (CATS:ROVI) markets in the Pharma Sector Medical Technology Biotechnology Peter George, CEO Pharmaceuticals Bernard Gilly, Executive Chairman Prabhavathi Fernandes, Ph.D., Founder, Javier López-Belmonte, CFO President and CEO

1:00 PM Tissue Regenix Group Plc (AIM:TRX) Cubist Pharmaceuticals Inc. Orpea S.A. (ENXTPA:ORP) IDT Biologika GmbH (Private) Bavarian Nordic A/S (CPSE:BAVA) Medical Technology (NasdaqGS:CBST) Healthcare Services Animal Health Biotechnology Biotechnology Antony Odell, CEO Steve Grobet, Investor Relations Officer Andreas Kastenbauer, COO & Dr. Paul Chaplin, President & CEO Steve Gilman, EVP & CSO Michael Hemprich, Head of Business Development

1:40 PM Novo Nordisk A/S (CPSE:NOVO B) Novozymes A/S (CPSE:NZYM B) MAXIMUS, Inc. (NYSE:MMS) Virbac SA (ENXTPA:VIRP) Progenics Pharmaceuticals, Inc. Pharmaceuticals Pharmaceuticals Healthcare Services Animal Health (NasdaqGS:PGNX) Biotechnology Peter Kurtzhals, SVP Diabetes Research Dave Mead, Business Development Richard Montoni, CEO Eric Maree, CEO Unit Director Jim Garrison, Head of Business Development and Commercial Strategy 2:20 PM Al Noor Hospitals Group Plc (LSE:ANH) Valeant Pharmaceuticals International Recipharm AB (OM:RECI B) Aratana Therapeutics, Inc. Galapagos NV ( ENXTBR:000381835) Healthcare Services (TSX:VRX) Pharmaceuticals (NasdaqGM:PETX) Biotechnology Sami Alom, Chief Strategy Officer & Pharmaceuticals Björn Westberg, CFO Animal Health Onno Van de Stolpe, CEO Director, Investor Relations Laurie Little, SVP, Investor Relations Steve St. Peter, President and CEO

3:00 PM Medical Properties Trust (NYSE:MPW) Akorn, Inc. (NasdaqGS:AKRX) ALK-Abello (CPSE:ALK B) Putney, Inc. (Private) MediWound Ltd. (NasdaqGM:MDWD) Services Pharmaceuticals Life Sciences Animal Health Pharmaceuticals Steve Hamner, CFO Tim Dick, CFO Flemming Pedersen, CFO and EVP Jean Hoffman, Founder, Chairman and Gal Cohen, CEO Chief Executive Officer

3:40 PM Forward Pharma A/S (NasdaqGS:FWP) Ipsen S.A (ENXTPA:IPN) Neurocrine Biosciences, Inc. Parnell Pharmaceuticals Holdings Ltd. Verastem, Inc. (NasdaqGM:VSTM) Biotechnology Pharmaceuticals (NasdaqGS:NBIX) (NasdaqGM:PARN) Biotechnology Joel Sendek, CFO Marc De Garidel, CEO Biotechnology Animal Health Robert Forrester, CEO Kevin Gorman, President & CEO Robert Joseph, CEO

4:20 PM GW Pharmaceuticals plc (AIM:GWP) OpKo Health, Inc (NYSE:OPK) SciClone Pharmaceuticals, Inc. Sequent Scientific Ltd. (BSE:512529) Prosensa Holding N.V. (NasdaqGS:RNA) Pharmaceuticals Pharmaceuticals (NasdaqGS:SCLN) Animal Health Biotechnology Justin Gover, CEO Steven Rubin, Executive Vice President - Biotechnology Manish Gupta, CEO Hans Schikan, CEO Admistration Friedhelm Blobel, CEO

5:00 PM Norgine (Private) Helsinn Healthcare SA (Private) Transgene SA (ENXTPA:TNG) Pharmaceuticals Pharmaceuticals Biotechnology Peter Stein, CEO Riccardo Braglia, CEO Elisabetta Castelli, Director, Investor Relations

Presenting companies and speakers are subject to change. AGENDA THURSDAY, NOVEMBER 20, 2014 Jefferies 2014 Global Healthcare Conference in London

TRACK 1 TRACK 2 TRACK 3 TRACK 4 TRACK 5 ADELPHI 1 ADELPHI 2 ADELPHI 3 EXECUTIVE BOARDROOM ALDWYCH 7:30 AM Breakfast and Registration

8:00 AM Stratec Biomedical AG (DB:SBS) Vectura Group Plc (LSE:VEC) NPS Pharmaceuticals Inc. Kamada Ltd. (TASE:KMDA) Syneron Medical Ltd. (NasdaqGS:ELOS) Life Sciences Pharmaceuticals (NasdaqGS:NPSP) Biotechnology Medical Products & Devices Marcus Wolfinger, CEO Dr Chris Blackwell, CEO Biotechnology Gil Efron, CFO Hugo Goldman, CFO Francois Nader, MD, President & CEO

8:40 AM Alere Inc. (NYSE:ALR) Avalanche Biotechnologies, Inc. Haemonetics Corp (NYSE:HAE) Innate Pharma S.A. (ENXTPA:IPH) AMCo (Private) Medical Technology (NasdaqGM:AAVL) Medical Products & Devices Biotechnology Pharmaceuticals Namal Nawana, Interim CEO Biotechnology Christopher Lindop, CFO & EVP, Business Herve Brailly, CEO John Beighton, CEO Linda Bain, CFO Development

9:20 AM AMAG Pharmaceuticals, Inc. AbbVie Inc. (NYSE:ABBV) Ascendis Health Limited (JSE:ASC) ACADIA Pharmaceuticals Inc. RIEMSER Pharma GmbH (Private) (NasdaqGS:AMAG) Pharmaceuticals Pharmaceuticals (NasdaqGS:ACAD) Pharmaceuticals Pharmaceuticals Bill Chase, Executive Vice President - Dr. Karsten Wellner, CEO Biotechnology Kai Deusch, CEO Bill Heiden, CEO Chief Operating Officer Uli Hacksell, CEO

10:00 AM PT Siloam International Hospitals Tbk Roche Holding Ltd. (SWX:ROG) Nektar Therapeutics (NasdaqGS:NKTR) Dicerna Pharmaceuticals, Inc. Alvogen Group (Private) (JKSE:SILO) Pharmaceuticals Biotechnology (NasdaqGS:DRNA) Pharmaceuticals Healthcare Facilities Bill Anderson, Head of Global Product Dr. Ivan Gergel, Chief Medical Officer Biotechnology Robert Wessman, CEO Dr. Gershu Paul, CEO Strategy and Chief Marketing Officer James Dentzer, CFO Kevin Bain, CFO 10:40 AM Abiomed Inc. H. Lundbeck A/S (CPSE:LUN) Kite Pharma, Inc. (NasdaqGS:KITE) Compugen Ltd. (NasdaqCM:CGEN) Doc Generici S.R.L. (Private) (NasdaqGS:ABMD) Pharmaceuticals Biotechnology Biotechnology Pharmaceuticals Medical Products Anders Gotzsche, CFO Arie Belldegrun, Chairman, President & Anat Cohen Dayag, President & CEO Gualtiero Pasquarelli, CEO Robert Bowen, Vice President & CFO CEO

11:20 AM Sorin SpA (BIT:SRN) Galenica Ltd. (SWX:GALN) Genmab AS (CPSE:GEN) Radius Health, Inc. (NasdaqGM:RDUS) MS Pharma (Private) Medical Products & Devices Pharmaceuticals Biotechnology Biotechnology Pharmaceuticals Andre-Michel Ballester, CEO Jorg Kneubuhler, CFO Jan van De Winkel, CEO Robert Ward, President & CEO Faisal Sukhtian, Owner

12:00 PM Break – Working Lunch

Presenting companies and speakers are subject to change. AGENDA THURSDAY, NOVEMBER 20, 2014 Jefferies 2014 Global Healthcare Conference in London

TRACK 1 TRACK 2 TRACK 3 TRACK 4 TRACK 5 ADELPHI 1 ADELPHI 2 ADELPHI 3 EXECUTIVE BOARDROOM ALDWYCH 12:20 PM AcelRx Pharmaceuticals, Inc. Skyepharma PLC (LSE:SKP) ERYTECH Pharma Societe Anonyme Arrowhead Research Corporation Amneal Pharmaceuticals (Private) (NasdaqGM:ACRX) Pharmaceuticals Biotechnology (NasdaqGS:ARWR) Pharmaceuticals Biotechnology Gil Beyen, Chairman and CEO Biotechnology Peter Grant, Finance Director Chirag Patel, Co-Chairman and Co-CEO Richard King, President & CEO Christopher Anzalone, CEO

1:00 PM PAREXEL International Corporation Orion Corp. (HLSE:ORNBV) BioDelivery Sciences International, Inc. Hyperion Therapeutics, Inc. Polpharma S.A. (Private) (NasdaqGS:PRXL) Pharmaceuticals (NasdaqCM:BDSI) (NasdaqGS:HPTX) Pharmaceuticals Healthcare Services Biotechnology Biotechnology Jari Karlson, CFO Piotr Hrycaj, M&A Director Ingo Bank, Senior Vice President and Mark Sirgo, President & CEO Donald Santel, President & CEO

Chief Operating Officer

1:40 PM Syngene International (Biocon Limited) Lannett Co Inc (AMEX:LCI) MorphoSys AG (XTRA:MOR) Merrimack Pharmaceuticals, Inc. NextPharma GmbH (Private) (Private) Pharmaceuticals Biotechnology (NasdaqGM:MACK) Pharmaceuticals Healthcare Services Arthur Bedrosian, CEO Jens Holstein, CFO Biotechnology Andrew Kelley, C.O.O. Peter Bain, CEO Robert Mulroy, President and CEO

2:20 PM WuXi PharmaTech (Cayman) Inc. Recordati SpA (BIT:REC) Novavax, Inc. (NasdaqGS:NVAX) NewLink Genetics Corporation Mologen AG (NYSE:WX) Pharmaceuticals Biotechnology (NasdaqGM:NLNK) (DB:MGN) Healthcare Services Walter Bevilacqua, VP Corporate Stan Erck, CEO Biotechnology Biotechnology Edward Hu, CFO Development Charles Link, CEO Dr. Matthias Schroff, CEO

3:00 PM UDG Healthcare plc (LON:UDG) Merck & Co. Inc. (NYSE:MRK) Lee's Pharmaceutical Holdings Ltd. Array BioPharma, Inc. (NasdaqGM:ARRY) Symetis SA (Private) Healthcare Services Pharmaceuticals (SEHK:950) Biotechnology Pharmaceuticals Liam Fitzgerald, CEO & Alan Ralph, CFO Adam Schechter, EVP, Global Human Pharmaceuticals Ron Squarer, CEO Jacques Essinger, CEO Health Mauro Bove, Member of the Board

3:40 PM Smith & Nephew plc (LSE:SN.) XOMA Corporation (NasdaqGM:XOMA) BioMarin Pharmaceutical Inc. Macrocure Ltd. (NasdaqGM:MCUR) GC Aesthetics (Private) Medical Products & Devices Biotechnology (NasdaqGS:BMRN) Biotechnology Medical Products & Devices Julie Brown, CFO John Varian, CEO Biotechnology Nissim Mashiach, President & CEO Ayse Kocak, CEO JJ Bienaimé, CEO

4:20 PM Affimed Therapeutics B.V. Cegedim SA (ENXTPA:CGM) Neostem, Inc. (NasdaqCM:NBS) Nanolek Holding Ltd (Private) Moberg Pharma AB (NasdaqGM:AFMD) Health Care Technology Biotechnology Pharmaceuticals (OM:MOB) Biotechnology Jan Eryk Umiastowski, Chief investment Robin Smith, Chairman and CEO Evgeny Barinov, CFO Pharmaceuticals Adi Hoess, CEO Officer & Head of Investor Relations Peter Wolpert, CEO and Founder

5:00 PM Kindred Biosciences, Inc. (NasdaqCM:KIN) Animal Health Denise Bevers, Chief Operating Officer

Presenting companies and speakers are subject to change. PARTICIPATING

COMPANIES Jefferies 2014 Global Healthcare Conference in London

• Abbott Laboratories - B2B Only • arGEN-X N.V • Cosmo Pharmaceuticals SpA • AbbVie Inc. • Armetheon, Inc. • CTI BioPharma Corp. • Abiomed Inc • Array BioPharma, Inc. • Cubist Pharmaceuticals Inc. • Ablynx NV • Arrowhead Research Corporation • Daiichi Sankyo Company, Limited - B2B Only • ACADIA Pharmaceuticals Inc. • Ascendis Health AG NEW • David Colpman (Ex Head of Global Business • AcelRx Pharmaceuticals, Inc • Aslan Phama Development at Shire Pharma Ltd) • Acino Pharma AG • Arterium – B2B Only • DBV Technologies S.A. • Acorda Therapeutics, Inc • Auris Medical Holding AG • DCC plc • Actelion Ltd. • Auspex Pharmaceuticals • Dexcel Ltd B2Bs Only • ActoGeniX • Avalanche Biotech • Dicerna Pharmaceuticals, Inc. • Admedus GmbH • Basilea Pharmaceutica AG • Doc Generici S.R.L • Adocia Société Anonyme • Bavarian Nordic A/S • Dong-A Socio Holdings Co. Ltd. • Advanced Medical Solutions Group • Baxter Healthcare • Dopharma B.V. - B2Bs Only • Advanced Accelerator Applications • Bayer AG • Durbin Plc B2Bs Only • AQDOT Limited • Bimeda Holdings PLC • EMIS Group PLC • Affimed Therapeutics AG • BioDelivery Sciences International, Inc. • Enigma Diagnostics • Akorn, Inc. • Biofrontera • EPS International • Al Noor Hospitals Group Plc • BioMerieux S.A. • ERYTECH Pharma Societe Anonyme • Alcobra Pharma • Bio-Nabler FZ – B2B Only • Esteve - B2Bs Only • Alere Inc. • Bio Products – B2B Only • Ethypharm SA • Alexza Pharmaceuticals • BioQuiditty • Eurofins Scientific SA • ALK-Abello • BioSpecifics Technologies Corp. • EVA Pharma - B2Bs Only • Alliance Pharmaceuticals • Bristol-Myers Squibb Company • Faes Farma, S.A. - B2Bs Only • Alter Pharma NV • BTG • Famar S.A. • Altovida • C4X Discovery • Farmak JSC - • Alvogen Group • Cegedim SA • Ferring Pharmaceuticals • AMAG Pharmaceuticals, Inc. • Celgene Corporation • Forward Pharma A/S • Ambu A/S • Cempra, Inc. • Flamel Technologies SA • AMCo - B2Bs Only • Centrexion • Flynn Pharma • Amgen Inc. • Circassia Pharmaceuticals plc. • Fresenius SE & Co KGaA • Amneal Pharmaceuticals • Clinigen Group Plc • Galapagos NV • Anergis SA • Complix NV • Galenica Ltd. • Angelini Group - B2B Only • Compugen • Genmab AS • Anpario plc • Consilient Health • Genomic Vision, S.A. • Aratana Therapeutics, Inc. • Convergence Pharmaceuticals Limited • Georgia Healthcare Group

Presenting companies are subject to change. PARTICIPATING

COMPANIES Jefferies 2014 Global Healthcare Conference in London

• Gerresheimer AG • Lannett Co Inc • Norgine • Global Consolidation NEW • Lee's Pharmaceutical Holdings Ltd. • Novartis AG • GN Store Nord A/S • Lonzo Group AG • Novartis AG - B2B Only • Grunenthal Group - B2Bs Only • Linda Rosenstock (Linda Rosenstock is a public • Novavax, Inc. • Guillaume Jetten (Former CFO of Galapagos) health specialist at UCLA) • Novo Nordisk • GW Pharma • Lifebrain • Noxxon NEW • H. Lundbeck A/S • MacroCure • Novozymes A/S • Haemonetics Corp • Mainstay Medical Group • NPS Pharmaceuticals Inc. • Helsinn Healthcare SA • Martindale Pharma • Olainfarm • Henry Schein, Inc. • Marwood Group LLC • OpKo Health, Inc • Heptares Therapeutics Ltd • MAXIMUS, Inc. • Orexo AB • Hetero Drugs Limited • MD Medical Group Investments Plc • Mipharm SPA • Hikma Pharmaceuticals plc • Meda Pharmaceuticals - B2B Only • Orion Corp. • Horizon Pharma • Medical Properties Trust • Orpea S.A. • HRA Pharma - B2Bs Only • MediGene AG • Otto Bock Healthcare GmbH • Hyperion Therapeutics, Inc. • Medivation, Inc. • Oxford BioMedica Plc • i-Optics • Medivir AB • Pacira Pharmauceuticals, Inc. • IDT Biologika GmbH (Klocke Holding GmbH) • MediWound Ltd. • PAION AG • Immune Design Corp. • Menarini Group - B2Bs Only • Paras Biopharmaceuticals Ltd • ImmuPharma Plc • Merck & Co. Inc. • PAREXEL International Corporation • Impax Laboratories –B2B Only • Merrimack Pharmaceuticals • Parnell Holdings Limited • Innate Pharma S.A. • Moberg Pharma AB • PDL BioPharma, Inc. • Institut Pasteur • Mologen AG • PerkinElmer, Inc. • Intas Pharmaceuticals Ltd • MorphoSys AG • Pernix Therapeutics • Intelesens • MS Pharma • Perrigo - B2Bs Only • Interros Company – B2B Only • Mylan, Inc. - B2Bs Only • Pharmagenix AG • Intrapharm Laboratories Ltd - B2B Only • Nanolek Holding • Philip Morris International Inc • Ion Beam Applications • Nektar Therapeutics • PhotoCure ASA • Ipsen S.A. • Neostem, Inc. • PIC – B2B Only • Italfarmaco • Neurocrine Biosciences, Inc. • Pixium Vision • Kamada Ltd. • NeuroVive Pharmaceuticals • Polpharma S.A.B2B only • Kindred Biosciences, Inc. • NewLink Genetics Corporation • Poxel Pharmaceuticals • Kite Pharma, Inc. • NextPharma GmbH • Premune AB • Oncompass GMBH • Noden Pharma Inc – B2B Only • Primary Health Properties PLC • Laboratorios Farmaceuticos ROVI • Norbrook Laboratories Ltd – B2B Only • Probiodrug AG NEW

Presenting companies are subject to change. PARTICIPATING

COMPANIES Jefferies 2014 Global Healthcare Conference in London

• Progenics Pharmaceuticals, Inc. • STENTYS • Prosensa Holding N.V. • Stratec Biomedical AG • Prosonix • Stuart Swanson (co-founder of AMICUS S.A.) • ProStrakan Group PLC • Swedish Orphan Biovitrum AB • Protalix BioTherapeutics • Symetis SA • Protek • Syneron Medical Ltd. • PT Siloam International Hospitals Tbk • Syngene International (Biocon Limited) • Pulmagen Therapeutics LLP • Takeda Pharmaceuticals Co.Ltd • Putney Inc • TESARO • Qiagen N.V • ThromboGenics NV • Quanta Fluid Solutions Ltd. • Tillotts Pharma Ab • R-Pharm - B2B Only • Tissue Regenix Group Plc • Radius Health, Inc. • Transgene SA • Recipharm • Tunstall • Reckitt Benckiser Pharmaceuticals (Indivior) • UDG Healthcare plc • Recordati SpA • uniQure N.V. • Recordati SpA - B2B Only • UniLife Corporation • RedHill Biopharma Ltd • Valeant Pharmaceuticals International • ReWalk Robotics Ltd. • Valentech – B2Bs Only • Rhoen Klinikum AG • Vectura Group Plc • RIEMSER Pharma GmbH • Verastem, Inc. • Roche Holding Ltd • Vernalis • Rodolfo Savitzky (CFO, Animal Health at Novartis) • Vétoquinol SA - B2B Only • Sandoz • Virbac SA • Sartorius AG • WuXi PharmaTech (Cayman) Inc. • SciClone Pharmaceuticals, Inc. • XOMA Corporation • Sequent Scientific Ltd. • Zealand Pharma A/S • Shire plc. • Zeltia • Sigma-Tau Pharma Ltd. • • Sinocare - • Skyepharma PLC • Smith & Nephew plc • Sorin SpA • Spire Healthcare Group Plc

Presenting companies are subject to change.